Background
Gray font color on white background Black font color on white background White font color on black background White font color on dark blue background
Font Size
News & Events » Media Stories
Print E-mail Bookmark Share This Page

MIT Technology Review - July 14, 2011 - Two Patients Undergo Stem-Cell Blindness Treatment

Thursday, 14 July 2011

Chief Research Officer Dr. Stephen Rose weighs in on ACT’s clinical trials that use retinal cells derived from human stem cells to treat macular degeneration. The MIT Technology Review article appears online after ACT announced two patients were treated Tuesday in California.

Read the full article >

 

 
 

Back to top

US Images

Chapters

Select a state from the dropdown below to view local chapters.


Free Information

Register here to receive free information about your eye condition and research efforts to find treatments and cures.

2012 Annual Report banner
VISIONS 2013 - Side Box banner
VisionWalk banner
View all
Events Calendar